FCM
ALAB icon

Fieldview Capital Management’s Astera Labs ALAB Stock Holding History

Fieldview Capital Management’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,848
Closed -$949K – 680
2025
Q3 		$949K Sell
4,848
-2,162
-31% -$356K 0.16% 190
2025
Q2 		$634K Buy
+7,010
New +$554K 0.1% 224

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $14.3B AUM 116.01% 1-Year Est. Return

Fieldview Capital Management's ALAB Position: Q4 2025 in Review

Fieldview Capital Management sold out of Astera Labs (ALAB) in Q4 2025, closing a stake of 4,848 shares — an estimated $949K sold.

Fieldview Capital Management first reported a position in ALAB in Q2 2025 and held it in 2 quarters. The position peaked at $949K in Q3 2025. 701 funds tracked by Wall St. Rank hold ALAB as of Q4 2025.

  • Fieldview Capital Management reported no remaining Astera Labs position as of Q4 2025 after selling out during the quarter.
  • Fieldview Capital Management sold 4,848 Astera Labs shares in Q4 2025, an estimated $949K.
  • Fieldview Capital Management first reported a position in Astera Labs in Q2 2025 and held it in 2 quarters.
  • Fieldview Capital Management's Astera Labs position peaked at $949K in Q3 2025.
  • 701 funds tracked by Wall St. Rank held Astera Labs as of Q4 2025.

Based on Fieldview Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.